NICE approved Mounjaro for weight management (TA1026) in adults with a BMI of 35 or above with weight-related health conditions, or a BMI of 30 or above with specific comorbidities
The most frequently reported effects include temporary redness at the injection site, mild nausea, lightheadedness, and skin flushing
That said, theres not yet enough long-term data to rule out ongoing risk
If you prefer oral semaglutide over injections, PlexusDx offers that option at $289/mo month-to-month, or from $249/mo on the 6-month plan
Funding This work was supported by Novo Nordisk Foundation (Grant no
However, it should be noted that NLRP3 deficiency causes undesirable infection in mice [10], and MCC950 was not recommended in a phase II clinical trial for rheumatoid arthritis due to its liver toxicity [40]